<DOC>
	<DOC>NCT02434835</DOC>
	<brief_summary>The purpose of this study is to evaluate the absorption, metabolism and excretion following a single oral dose of [14C]KWA-0711 to healthy male subjects.</brief_summary>
	<brief_title>Study of Absorption, Metabolism and Excretion Following a Single Oral Dose of [14C]KWA-0711 to Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>Subjects who are male, caucasian, and between 35 and 55 years of age, inclusive. Subjects who have a body mass index (BMI) between 18.5 and 30.0 kg/m2, inclusive. Subjects who have a body weight between 50 and 100 kg, inclusive. Subjects must have regular bowel movements. Subjects who have an abnormality in heart rate, blood pressure , temperature or 12lead ECG. Subjects who are still participating in a clinical study or who have participated in a clinical study involving administration of an investigational drug in the 3 months prior to dose administration. Subjects who have had a clinically significant illness within 4 weeks of dose administration as determined by the Investigator. Subjects who have any clinically significant abnormal laboratory safety findings. Subjects who have had an X ray or who have participated in any clinical trial involving a radiolabelled investigational product or have been exposed to radiolabelled substances within 12 months prior to dose administration.</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>